A nurse is caring for a diabetic client who is scheduled for major abdominal surgery in the morning. The client's preoperative blood glucose level is 210 mg/dL, and the surgeon has ordered to proceed with surgery. What is the most appropriate nursing intervention to ensure optimal perioperative glucose management?

Continuous glucose monitoring with intraoperative insulin protocol provides the most comprehensive approach to managing diabetes during major surgery, allowing for real-time adjustments and optimal glucose control.

Perioperative blood glucose management in diabetic patients is crucial to prevent surgery-related complications. This question asks about the optimal blood glucose management method for a diabetic patient scheduled for major abdominal surgery.

Surgery places significant physiological stress on the body, leading to increases in stress hormones such as cortisol, epinephrine, and growth hormone. These hormones increase insulin resistance and raise blood glucose levels. The surgical stress response can persist for several days after surgery, requiring continuous monitoring.

Continuous glucose monitoring with an intraoperative insulin protocol is the standard method for perioperative diabetes management. This approach allows blood glucose to be maintained within the target range (typically 140-180 mg/dL) before, during, and after surgery. This significantly reduces the risk of surgical site infections, delayed wound healing, and other hyperglycemia-related complications.

Major abdominal surgery poses particular challenges for diabetic patients due to long operative times, significant fluid shifts, and the need for prolonged fasting. The combination of surgical stress, anesthetic effects, and metabolic changes requires dynamic blood glucose management, checking glucose every 1-2 hours and administering sliding-scale insulin based on current levels and anticipated changes.

Option 1 (administering the usual morning insulin dose) is inappropriate because it does not account for the blood glucose rise due to surgical stress. Option 2 (discontinuing all diabetes medications) can lead to severe hyperglycemia. Option 3 (halving the insulin dose) may result in inadequate glucose control in the setting of surgical stress. Option 4 is correct because it provides a comprehensive, evidence-based approach that can respond to real-time blood glucose changes.

Clinical Context
A preoperative blood glucose of 210 mg/dL in a diabetic client scheduled for major abdominal surgery represents hospital hyperglycemia, a condition that independently increases the risk of postoperative infections, prolongs hospital stay, and elevates in-hospital mortality. The surgeon’s decision to proceed does not eliminate the nurse’s responsibility to advocate for and implement evidence-based perioperative glycemic control strategies.

Why Option 4 is Correct
Initiating continuous glucose monitoring and preparing for an intraoperative insulin protocol aligns with the guideline recommendation that adequate glycemic control during the perioperative period reduces surgical complications and improves outcomes ^[1]. Continuous monitoring allows for real-time detection of fluctuations, while a standardized intravenous insulin infusion protocol provides the titration precision necessary to maintain glucose within a safe target range during the dynamic stress of major surgery. This approach directly addresses the pathophysiological risk: surgical stress triggers counter-regulatory hormone release (cortisol, catecholamines), promoting hepatic gluconeogenesis and insulin resistance, which can drive glucose even higher intraoperatively without proactive intervention.

Why the Other Options are Incorrect

Option 1: Administer the client's usual morning insulin dose as prescribed.
A client’s usual outpatient regimen is designed for a non-surgical, oral intake state. On the morning of major abdominal surgery, the client is typically NPO, and the physiological stress response alters insulin sensitivity unpredictably. Administering the usual dose without real-time, continuous data and a titratable intraoperative plan risks both hypoglycemia from fasting and hyperglycemia from surgical stress. The guideline emphasizes a structured perioperative protocol rather than simply continuing home medications ^[1].

Option 2: Hold all diabetes medications until after surgery is completed.
Withholding all glucose-lowering therapy in a patient already presenting with a blood glucose of 210 mg/dL would permit unopposed hyperglycemia throughout the intraoperative period. The position statement explicitly links perioperative hyperglycemia to increased complications, including infections and mortality ^[1]. This passive approach contradicts the evidence that active glycemic management must continue through the perioperative continuum.

Option 3: Give only half the usual insulin dose to prevent hypoglycemia.
While the concern for hypoglycemia during NPO status is valid, an arbitrary 50% reduction lacks individualization and does not constitute a comprehensive perioperative glucose management strategy. A fixed dose reduction cannot adapt to the dynamic metabolic changes of surgery. The guideline supports a protocol-driven, monitored approach—typically an intravenous insulin infusion with frequent glucose checks—rather than a one-time, empirically adjusted subcutaneous dose ^[1].

Pathophysiology and Clinical Reasoning
Major abdominal surgery triggers a neuroendocrine stress response, elevating cortisol, glucagon, and catecholamines. These hormones increase hepatic glucose production and peripheral insulin resistance, causing blood glucose to rise even in fasting patients. Pre-existing diabetes blunts the compensatory insulin response, making the patient vulnerable to severe hyperglycemia. Hyperglycemia impairs leukocyte function, including chemotaxis and phagocytosis, directly increasing surgical site infection risk. It also promotes a pro-inflammatory state and osmotic diuresis, which can lead to electrolyte imbalances and dehydration, complicating hemodynamic stability during anesthesia. Continuous monitoring with a protocol allows the nurse and anesthesia team to titrate insulin precisely, counteracting these effects and maintaining glucose in a range that minimizes complications ^[1].